Literature DB >> 7678163

Mutagenic activity of some platinum and palladium complexes.

Y Uno1, M Morita.   

Abstract

The mutagenic properties of 16 platinum compounds were studied using Salmonella typhimurium TA98 and TA100. Eight of the compounds were considered direct mutagens, as their mutagenicity was not dependent on metabolic activation by liver extracts. Potent mutagenicity and high toxicity were exhibited by cis-Pt(NH3)2Br2, cis-Pt(NH3)2Cl2, Pt(C5H12N2)Cl2 and Pt(en)Cl2 for both bacterial strains. When distilled water was used as the carrier solvent, these compounds were strongly mutagenic and toxic, but much less so when dimethyl sulfoxide was the solvent.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7678163     DOI: 10.1016/0165-1218(93)90006-y

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  5 in total

1.  Cyto- and genotoxic effects of coordination complexes of platinum, palladium and rhodium in vitro.

Authors:  J Bünger; J Stork; K Stalder
Journal:  Int Arch Occup Environ Health       Date:  1996       Impact factor: 3.015

2.  Cisplatin loaded albumin mesospheres for lung cancer treatment.

Authors:  Hung-Yen Lee; Kamal A Mohammed; Eugene P Goldberg; Frederic Kaye; Najmunnisa Nasreen
Journal:  Am J Cancer Res       Date:  2015-01-15       Impact factor: 6.166

3.  Urinary platinum in hospital personnel occupationally exposed to platinum-containing antineoplastic drugs.

Authors:  A S Ensslin; A Pethran; R Schierl; G Fruhmann
Journal:  Int Arch Occup Environ Health       Date:  1994       Impact factor: 3.015

4.  The influence of organic solvents on estimates of genotoxicity and antigenotoxicity in the SOS chromotest.

Authors:  Nathalia Quintero; Elena E Stashenko; Jorge Luis Fuentes
Journal:  Genet Mol Biol       Date:  2012-06-23       Impact factor: 1.771

5.  Lipocalin2 Protects Human Embryonic Kidney Cells against Cisplatin-Induced Genotoxicity.

Authors:  Fatemeh Sadeghi; Mahmoud Etebari; Mehryar Habibi Roudkenar; Ali Jahanian-Najafabadi
Journal:  Iran J Pharm Res       Date:  2018       Impact factor: 1.696

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.